Thrivent Financial for Lutherans Cuts Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Thrivent Financial for Lutherans lowered its position in Addus HomeCare Co. (NASDAQ:ADUS) by 1.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 13,861 shares of the company’s stock after selling 195 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Addus HomeCare were worth $1,737,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Quarry LP acquired a new position in shares of Addus HomeCare in the 3rd quarter valued at about $28,000. Smartleaf Asset Management LLC raised its holdings in Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after buying an additional 214 shares during the period. Parkside Financial Bank & Trust lifted its position in Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock valued at $67,000 after buying an additional 148 shares in the last quarter. KBC Group NV grew its stake in Addus HomeCare by 49.1% during the fourth quarter. KBC Group NV now owns 814 shares of the company’s stock worth $102,000 after buying an additional 268 shares during the period. Finally, GAMMA Investing LLC increased its position in shares of Addus HomeCare by 34.5% in the fourth quarter. GAMMA Investing LLC now owns 1,258 shares of the company’s stock worth $158,000 after acquiring an additional 323 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Trading Down 0.5 %

Addus HomeCare stock opened at $97.30 on Friday. Addus HomeCare Co. has a 52 week low of $87.88 and a 52 week high of $136.72. The stock has a market cap of $1.77 billion, a P/E ratio of 22.27, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97. The stock has a 50 day moving average of $108.31 and a 200-day moving average of $120.67.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The company had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. As a group, equities analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Insider Transactions at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the sale, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 4.60% of the company’s stock.

Wall Street Analyst Weigh In

ADUS has been the topic of several recent research reports. Oppenheimer lifted their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Macquarie restated an “outperform” rating and set a $129.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 27th. JMP Securities assumed coverage on Addus HomeCare in a research report on Monday, December 16th. They issued an “outperform” rating and a $150.00 target price for the company. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Finally, StockNews.com cut Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. One analyst has rated the stock with a sell rating, one has given a hold rating, seven have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $132.78.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.